Focus on Diabetes Care

Back to articles

Slight increase in glycemic durability with insulin lispro mix versus glargine in patients with type 2 diabetes

KEY POINT

According to a recent trial, treatment with twice-daily insulin lispro mix 75/25 achieved modestly longer durability of glycemic control compared with once-daily insulin glargine (Lantus—sanofi aventis) when added to oral antihyperglycemic drugs in patients with type 2 diabetes.